C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
03/2011
03/31/2011	WO2010111381A3 Useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmethyl]-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-one
03/31/2011	WO2010102212A3 Neurotrophin mimetics and uses thereof
03/31/2011	WO2010093787A3 Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition
03/31/2011	WO2010093726A3 Large stokes shift dyes
03/31/2011	WO2010085749A3 Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability
03/31/2011	WO2010083501A3 Alpha-helix mimetic using a 2,5-oligopyrimidine scaffold
03/31/2011	WO2009077858A3 Hemioxalate salt of eletriptan
03/31/2011	US20110077400 Processes for preparing tetrahydroisoquinolines
03/31/2011	US20110077399 Substituted Azole Derivatives as Therapeutic Agents
03/31/2011	US20110077290 Heterocyclic compounds and thrombopoietin receptor activators
03/31/2011	US20110077280 Hepatitis C Virus Inhibitors
03/31/2011	US20110077273 New benzimidazole derivatives
03/31/2011	US20110077272 Pulmonary formulations of triptans
03/31/2011	US20110077265 Inhibitors of iap
03/31/2011	US20110077254 Compounds
03/31/2011	US20110077252 Pyridyl derivatives, their preparation and use
03/31/2011	US20110077246 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same
03/31/2011	US20110077245 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
03/31/2011	US20110077242 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
03/31/2011	US20110077241 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
03/31/2011	US20110077236 New carboxylic acid amides, the preparation thereof and their use as medicaments
03/31/2011	US20110077233 C-Met Modulators and Method of Use
03/31/2011	US20110074491 Photoelectric conversion device, photoelectric conversion device material, photosensor and imaging device
03/31/2011	CA2771026A1 Indole derivatives as crac modulators
03/31/2011	CA2770278A1 Pyrazoline dione derivatives as nadph oxidase inhibitors
03/30/2011	EP2301935A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
03/30/2011	EP2301929A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
03/30/2011	EP2301928A1 Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
03/30/2011	EP2301627A1 Novel antimalarial 3-azabicyclo[3.2.2]nonane derivatives
03/30/2011	EP2300459A1 Novel phenylpyrazinones as kinase inhibitors
03/30/2011	EP2300458A1 Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
03/30/2011	EP2300454A1 Novel Microbiocides
03/30/2011	EP2300438A1 Imidazole derivatives useful as inhibitors of faah
03/30/2011	EP2300435A2 Heterocyclic compounds as factor ixa inhibitors
03/30/2011	EP2300422A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
03/30/2011	EP2299824A1 Pyrazole derivatives useful as inhibitors of faah
03/30/2011	EP1833821B1 Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases
03/30/2011	EP1441719B1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
03/30/2011	EP1277738B1 Condensed heteroaryl derivatives
03/30/2011	CN101998954A Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors
03/30/2011	CN101998953A 2-phenyl-4-cyclopropyl-pyrimidine derivatives
03/30/2011	CN101998952A Hepatitis c virus inhibitors
03/30/2011	CN101993538A Triazole diamine-containing modified bismaleimide resin and preparation method thereof
03/30/2011	CN101993435A Triazole ring and ether bond-containing maleimide, and preparation method and use of resin thereof
03/30/2011	CN101993434A Acetylenyl terminated triazole imide low polymer and preparation method thereof
03/30/2011	CN101993433A Olmesartan organic amine salt, preparation method and application thereof
03/30/2011	CN101993432A Carbazoles chalcone derivatives based on carbazole and preparation method thereof
03/30/2011	CN101993409A Heterocyclic compound, organic light-emitting device containing polycyclic heteroaryl compounds
03/29/2011	US7915408 Triazolotriazines as kinase inhibitors
03/29/2011	US7915291 Hepatitis C virus inhibitors
03/29/2011	US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same
03/29/2011	US7915270 Oxazole ketones as modulators of fatty acid amide hydrolase
03/29/2011	US7915268 And 8-substituted 2-(imidazolo[4,5-c]pyridinyl)purines; Janus kinase 3 inhibitors; autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection
03/29/2011	US7915260 Urotensin II receptor antagonists
03/29/2011	US7915256 Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
03/29/2011	US7914706 Charge transport compositions and electronic devices made with such compositions
03/29/2011	CA2489276C Tricyclic steroid hormone nuclear receptor modulators
03/29/2011	CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/29/2011	CA2383779C N-(indolecarbonyl)piperazine derivatives
03/24/2011	WO2011035332A1 Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators
03/24/2011	WO2011035110A2 Treatment for oxidative stress and/or hypertension
03/24/2011	WO2011034967A1 Compounds for organic light emitting diode emissive layers
03/24/2011	WO2011034518A1 Hcv protease inhibitors
03/24/2011	WO2011034078A1 Glycine compound
03/24/2011	WO2011033472A1 Salts of sunitinib
03/24/2011	WO2011032903A1 Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/24/2011	WO2011032277A1 Quinazolinone derivatives as viral polymerase inhibitors
03/24/2011	WO2010132684A3 Inhibitors of inv(16) leukemia
03/24/2011	WO2010129053A3 Egfr inhibitors and methods of treating disorders
03/24/2011	US20110071302 Process for preparing intermediate compound for synthesizing an antiulcerant
03/24/2011	US20110071291 Hydrazide compound and pesticidal use of the same
03/24/2011	US20110071289 Aminopyrazole amide derivative
03/24/2011	US20110071175 Indoles and Their Therapeutic Use
03/24/2011	US20110071163 Use of an opioid receptor antagonist for the treatment or prevention of gastrointestinal tract disorders
03/24/2011	US20110071158 New compounds
03/24/2011	US20110071156 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
03/24/2011	US20110071154 Pyrrolidin-3-ylmethyl-amine as orexin antagonists
03/24/2011	US20110071153 Dihydropyrazole derivatives as tyrosine kinase modulators for the treatment of tumors
03/24/2011	US20110071152 5-membered heterocycle-based p38 kinase inhibitors
03/24/2011	US20110071150 Indole derivatives as crac modulators
03/24/2011	US20110071149 Selective kinase inhibitors
03/24/2011	US20110071145 Raf Modulators And Methods Of Use
03/24/2011	US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them
03/24/2011	US20110071134 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
03/24/2011	US20110071132 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof
03/24/2011	US20110071130 2-aminobenzimidazoles for treating neurodegenerative diseases
03/24/2011	US20110071126 Inhibitors of beta-secretase
03/24/2011	US20110071125 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
03/24/2011	US20110071084 Benzazepine derivatives useful as vasopressin antagonists
03/24/2011	US20110070596 Agents and methods for analyzing protein interactions
03/24/2011	US20110070297 Glucokinase activators
03/24/2011	US20110070197 Hepatitis c virus inhibitors
03/24/2011	US20110070196 Hepatitis c virus inhibitors
03/24/2011	US20110070193 Anti-Infective Agents and Uses Thereof
03/24/2011	US20110070192 Method of preparation of novel nucleoside analogs and uses
03/24/2011	US20110070189 Heterocyclic antiviral compounds
03/24/2011	US20110070166 Reduced dye probes for the detection of radical oxygen species
03/24/2011	US20110069130 Multifunctional type ii photoinitiators and curable compositions
03/24/2011	CA2774634A1 Salts of sunitinib
03/24/2011	CA2774239A1 Treatment for oxidative stress and/or hypertension

1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 626